Evidence map›Paper›PMID 31392271›Full record

ArticleScience advances2019

Cyclooxygenase 2 augments osteoblastic but suppresses chondrocytic differentiation of CD90

Samiksha Wasnik, Ram Lakhan, David J Baylink, Charles H Rundle, Yi Xu, Jintao Zhang, Xuezhong Qin, Kin-Hing William Lau, Edmundo E Carreon, Xiaolei Tang

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Hope for bone regeneration: The versatility of iron oxide nanoparticles.Frontiers in bioengineering and biotechnology · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Samiksha WasnikDivision of Regenerative Medicine, Department of Medicine, Loma Linda University, Loma Linda, CA, USA.ORCID 0000-0001-6097-0517
Ram LakhanDivision of Regenerative Medicine, Department of Medicine, Loma Linda University, Loma Linda, CA, USA.ORCID 0000-0002-2700-6272
David J BaylinkDivision of Regenerative Medicine, Department of Medicine, Loma Linda University, Loma Linda, CA, USA.
Charles H RundleMusculoskeletal Disease Center, Jerry L. Pettis Memorial Veterans Affairs Medical Center, Loma Linda, CA, USA.
Yi XuDivision of Regenerative Medicine, Department of Medicine, Loma Linda University, Loma Linda, CA, USA.
Jintao ZhangDivision of Regenerative Medicine, Department of Medicine, Loma Linda University, Loma Linda, CA, USA.
Xuezhong QinDivision of Regenerative Medicine, Department of Medicine, Loma Linda University, Loma Linda, CA, USA.
Kin-Hing William LauDivision of Regenerative Medicine, Department of Medicine, Loma Linda University, Loma Linda, CA, USA.ORCID 0000-0003-1109-5052
Edmundo E CarreonDivision of Regenerative Medicine, Department of Medicine, Loma Linda University, Loma Linda, CA, USA.
Xiaolei TangDivision of Regenerative Medicine, Department of Medicine, Loma Linda University, Loma Linda, CA, USA.ORCID 0000-0003-1492-9622
Loma Linda University · USJerry L. Pettis Memorial VA Medical Center · US

Funding

BLR&D Research Career Scientist AwardIK6BX003782 · VA · VA LOMA LINDA HEALTHCARE SYSTEM · PI LAU, KIN-HING WILLIAM · 2017 to 2021
–
BLRD VA IK6 BX003782
6 · The paper itself

Abstract

Cyclooxygenase 2 (COX-2) is essential for normal tissue repair. Although COX-2 is known to enhance the differentiation of mesenchymal stem cells (MSCs), how COX-2 regulates MSC differentiation into different tissue-specific progenitors to promote tissue repair remains unknown. Because it has been shown that COX-2 is critical for normal bone repair and local COX-2 overexpression in fracture sites accelerates fracture repair, this study aimed to determine the MSC subsets that are targeted by COX-2. We showed that CD90

Indexed as

AnimalsBone RegenerationCell DifferentiationChondrocytesCyclooxygenase 2Fractures, BoneGene Expression Regulation, DevelopmentalHumansLeukocyte Common AntigensMesenchymal Stem CellsMiceOsteoblastsOsteogenesisReceptor, TIE-2Thy-1 AntigensWnt Signaling PathwayCyclooxygenase 2Leukocyte Common AntigensPtgs2 protein, mouseReceptor, TIE-2Tek protein, mouseThy-1 Antigens

Identifiers

PMID31392271
PMCPMC6669009
OpenAlexW2965746055

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.